Αρχειοθήκη ιστολογίου

Πέμπτη 10 Αυγούστου 2017

Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2)

Pancreatic cancer is susceptible to gemcitabine resistance, and patients receive less benefit from gemcitabine chemotherapy. Previous studies report that gambogic acid possesses antineoplastic properties; howe...

from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2vmYoYd

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου